Astragalus Polysaccharides Augment BMSC Homing Via SDF-1/CXCR4 Modulation: a Novel Approach to Counteract Peritoneal Mesenchymal Transformation and Fibrosis

Overview

Journal BMC Complement Med Ther

Publisher Biomed Central

Specialty Rehabilitation Medicine

Date 2024 May 24

PMID 38789949

Authors

Funing Wang

Huibo Dai

Ziren Zhou

Yun Shan

Manshu Yu

Jinyi Sun

Li Sheng

Liyan Huang

Xiaohui Meng

Yongqing You

Meixiao Sheng

Affiliations

Soon will be listed here.

Abstract

Purpose: This study aimed to evaluate the potential of astragalus polysaccharide (APS) pretreatment in enhancing the homing and anti-peritoneal fibrosis capabilities of bone marrow mesenchymal stromal cells (BMSCs) and to elucidate the underlying mechanisms.

Methods: Forty male Sprague-Dawley rats were allocated into four groups: control, peritoneal dialysis fluid (PDF), PDF + BMSCs, and PDF + BMSCs (APS-pre-treated BMSCs). A peritoneal fibrosis model was induced using PDF. Dil-labeled BMSCs were administered intravenously. Post-transplantation, BMSC homing to the peritoneum and pathological alterations were assessed. Stromal cell-derived factor-1 (SDF-1) levels were quantified via enzyme-linked immunosorbent assay (ELISA), while CXCR4 expression in BMSCs was determined using PCR and immunofluorescence. Additionally, a co-culture system involving BMSCs and peritoneal mesothelial cells (PMCs) was established using a Transwell setup to examine the in vitro effects of APS on BMSC migration and therapeutic efficacy, with the CXCR4 inhibitor AMD3100 deployed to dissect the role of the SDF-1/CXCR4 axis and its downstream impacts.

Results: In vivo and in vitro experiments confirmed that APS pre-treatment notably facilitated the targeted homing of BMSCs to the peritoneal tissue of PDF-treated rats, thereby amplifying their therapeutic impact. PDF exposure markedly increased SDF-1 levels in peritoneal and serum samples, which encouraged the migration of CXCR4-positive BMSCs. Inhibition of the SDF-1/CXCR4 axis through AMD3100 application diminished BMSC migration, consequently attenuating their therapeutic response to peritoneal mesenchyme-to-mesothelial transition (MMT). Furthermore, APS upregulated CXCR4 expression in BMSCs, intensified the activation of the SDF-1/CXCR4 axis's downstream pathways, and partially reversed the AMD3100-induced effects.

Conclusion: APS augments the SDF-1/CXCR4 axis's downstream pathway activation by increasing CXCR4 expression in BMSCs. This action bolsters the targeted homing of BMSCs to the peritoneal tissue and amplifies their suppressive influence on MMT, thereby improving peritoneal fibrosis.

Citing Articles

ELABELA promotes the migration and homing of bone marrow mesenchymal stem cells to myocardial injury sites through the ERK1/2/miR-299a-5p/Exo70 pathway.

Hou J, Wu H, Li S, Li X, Yang S, Chen X Front Pharmacol. 2025; 16:1541869.

PMID: 39963243 PMC: 11831049. DOI: 10.3389/fphar.2025.1541869.

Integrated serum metabolomics and network pharmacology reveal molecular mechanism of Qixue Huazheng formula on peritoneal fibrosis.

Meng X, Sheng L, You Y, Dai H, Yu M, Wang F Front Pharmacol. 2025; 16:1515038.

PMID: 39917615 PMC: 11799242. DOI: 10.3389/fphar.2025.1515038.

References

Xie J, Wang H, Song T, Wang Z, Li F, Ma J . Tanshinone IIA and astragaloside IV promote the migration of mesenchymal stem cells by up-regulation of CXCR4. Protoplasma. 2012; 250(2):521-30. DOI: 10.1007/s00709-012-0435-1. View

Al-Amoodi A, Li Y, Al-Ghuneim A, Allehaibi H, Isaioglou I, Esau L . Refining the migration and engraftment of short-term and long-term HSCs by enhancing homing-specific adhesion mechanisms. Blood Adv. 2022; 6(15):4373-4391. PMC: 9636332. DOI: 10.1182/bloodadvances.2022007465. View

Liu D, Ye Y, Xu L, Yuan W, Zhang Q . Icariin and mesenchymal stem cells synergistically promote angiogenesis and neurogenesis after cerebral ischemia via PI3K and ERK1/2 pathways. Biomed Pharmacother. 2018; 108:663-669. DOI: 10.1016/j.biopha.2018.09.071. View

Wang N, Shao Y, Mei Y, Zhang L, Li Q, Li D . Novel mechanism for mesenchymal stem cells in attenuating peritoneal adhesion: accumulating in the lung and secreting tumor necrosis factor α-stimulating gene-6. Stem Cell Res Ther. 2012; 3(6):51. PMC: 3580481. DOI: 10.1186/scrt142. View

Ueno T, Nakashima A, Doi S, Kawamoto T, Honda K, Yokoyama Y . Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-β1 signaling. Kidney Int. 2013; 84(2):297-307. PMC: 3731556. DOI: 10.1038/ki.2013.81. View

Ullah M, Liu D, Thakor A . Mesenchymal Stromal Cell Homing: Mechanisms and Strategies for Improvement. iScience. 2019; 15:421-438. PMC: 6529790. DOI: 10.1016/j.isci.2019.05.004. View

He X, Li C, Yin H, Tan X, Yi J, Tian S . Mesenchymal stem cells inhibited the apoptosis of alveolar epithelial cells caused by ARDS through CXCL12/CXCR4 axis. Bioengineered. 2022; 13(4):9060-9070. PMC: 9161978. DOI: 10.1080/21655979.2022.2052652. View

Todorova V, Baxan N, Delahaye M, Harding S, Rankin S . Drug-based mobilisation of mesenchymal stem/stromal cells improves cardiac function post myocardial infarction. Dis Model Mech. 2022; 16(5). PMC: 10655717. DOI: 10.1242/dmm.049630. View

Bastug F, Gunduz Z, Tulpar S, Torun Y, Akgun H, Dorterler E . Compare the effects of intravenous and intraperitoneal mesenchymal stem cell transplantation on ultrafiltration failure in a rat model of chronic peritoneal dialysis. Ren Fail. 2014; 36(9):1428-35. DOI: 10.3109/0886022X.2014.945216. View

10.

Kim S, Jiang K, Chen X, Puranik A, Zhu X, Lerman A . Selective kidney targeting increases the efficacy of mesenchymal stromal/stem cells for alleviation of murine stenotic-kidney senescence and damage. J Tissue Eng Regen Med. 2022; 16(6):550-558. PMC: 9167737. DOI: 10.1002/term.3299. View

11.

Mukkala A, Jerkic M, Khan Z, Szaszi K, Kapus A, Rotstein O . Therapeutic Effects of Mesenchymal Stromal Cells Require Mitochondrial Transfer and Quality Control. Int J Mol Sci. 2023; 24(21). PMC: 10647450. DOI: 10.3390/ijms242115788. View

12.

Zhang L, Yong W, Wang L, Zhang L, Zhang Y, Gong H . Astragalus Polysaccharide Eases G1 Phase-Correlative Bystander Effects through Mediation of TGF- R/MAPK/ROS Signal Pathway After Carbon Ion Irradiation in BMSCs. Am J Chin Med. 2019; 47(3):595-612. DOI: 10.1142/S0192415X19500319. View

13.

Zheng Y, Ren W, Zhang L, Zhang Y, Liu D, Liu Y . A Review of the Pharmacological Action of Astragalus Polysaccharide. Front Pharmacol. 2020; 11:349. PMC: 7105737. DOI: 10.3389/fphar.2020.00349. View

14.

Samakova A, Gazova A, Sabova N, Valaskova S, Jurikova M, Kyselovic J . The PI3k/Akt pathway is associated with angiogenesis, oxidative stress and survival of mesenchymal stem cells in pathophysiologic condition in ischemia. Physiol Res. 2019; 68(Suppl 2):S131-S138. DOI: 10.33549/physiolres.934345. View

15.

Xiong W, Guo X, Cai X . SDF-1/CXCR4 axis promotes osteogenic differentiation of BMSCs through the JAK2/STAT3 pathway. Folia Histochem Cytobiol. 2021; 59(3):187-194. DOI: 10.5603/FHC.a2021.0020. View

16.

Li L, Chu L, Ren C, Wang J, Sun S, Li T . Enhanced Migration of Bone Marrow-Derived Mesenchymal Stem Cells with Tetramethylpyrazine and Its Synergistic Effect on Angiogenesis and Neurogenesis After Cerebral Ischemia in Rats. Stem Cells Dev. 2019; 28(13):871-881. DOI: 10.1089/scd.2018.0254. View

17.

Tan C, Tan S, Zhang H, Zhang M, Fan H, Nan Z . Enhanced migration and immunoregulatory capacity of BMSCs mediated by overexpression of CXCR4 and IL-35. Mol Immunol. 2022; 150:1-8. DOI: 10.1016/j.molimm.2022.07.005. View

18.

Xiu G, Li X, Yin Y, Li J, Li B, Chen X . SDF-1/CXCR4 Augments the Therapeutic Effect of Bone Marrow Mesenchymal Stem Cells in the Treatment of Lipopolysaccharide-Induced Liver Injury by Promoting Their Migration Through PI3K/Akt Signaling Pathway. Cell Transplant. 2020; 29:963689720929992. PMC: 7563832. DOI: 10.1177/0963689720929992. View

19.

Brown E, Zhao J, McCullough K, Fuller D, Figueiredo A, Bieber B . Burden of Kidney Disease, Health-Related Quality of Life, and Employment Among Patients Receiving Peritoneal Dialysis and In-Center Hemodialysis: Findings From the DOPPS Program. Am J Kidney Dis. 2021; 78(4):489-500.e1. DOI: 10.1053/j.ajkd.2021.02.327. View

20.

Li M, Yu L, She T, Gan Y, Liu F, Hu Z . Astragaloside IV attenuates Toll-like receptor 4 expression via NF-κB pathway under high glucose condition in mesenchymal stem cells. Eur J Pharmacol. 2012; 696(1-3):203-9. DOI: 10.1016/j.ejphar.2012.09.033. View